HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community.

AbstractOBJECTIVES:
To determine HLA-DR4 and DR1 allele frequencies in a series of patients with newly diagnosed early inflammatory arthritis.
METHODS:
HLA-DR1 and DR4 frequencies were determined by oligonucleotide typing of 208 patients classified as having either rheumatoid arthritis (RA) or undifferentiated inflammatory polyarthritis.
RESULTS:
The frequency of occurrence of DR4 in these patients with RA did not differ significantly from that in controls in the United Kingdom (42 v 37%). HLA-DR1 was increased in the group with inflammatory polyarthritis (25 v 18%).
CONCLUSIONS:
The frequency of DR4 is not increased in newly diagnosed community based patients with RA. This supports the hypothesis that DR4 is less important as a marker for susceptibility to RA than it is for disease persistence or severity.
AuthorsW Thomson, L Pepper, A Payton, D Carthy, D Scott, W Ollier, A Silman, D Symmons
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 52 Issue 7 Pg. 539-41 (Jul 1993) ISSN: 0003-4967 [Print] England
PMID8346982 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-DR Antigens
  • HLA-DR1 Antigen
  • HLA-DR4 Antigen
  • HLA-DRB1 Chains
  • Histocompatibility Antigens Class II
  • Oligonucleotide Probes
Topics
  • Arthritis, Rheumatoid (genetics)
  • Base Sequence
  • Genes, MHC Class II (genetics)
  • HLA-DR Antigens (genetics)
  • HLA-DR1 Antigen (genetics)
  • HLA-DR4 Antigen (genetics)
  • HLA-DRB1 Chains
  • Histocompatibility Antigens Class II (genetics)
  • Humans
  • Molecular Sequence Data
  • Odds Ratio
  • Oligonucleotide Probes
  • Polymerase Chain Reaction
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: